Two synthetic hosts, Wren and Ash, on the tracker's current state. The script was checked claim by claim against the tracker page and the cited sources below; every claim carries a verbatim quote.
Transcript
Wren Compass says one more dose keeps depression relief going a full year.
Ash That's 52-week Phase 3 data, and a 2027 launch is in sight. Before, the benefit lasted to 6 months.
Wren But the headline effect was modest, 3.8 points on a depression scale over 1 mg. And this follow-up is open-label, so everyone knew their dose.
Ash Still, it's over 1,000 patients, and two doses beat one. Plus a priority voucher cuts FDA review to 1-2 months.
Wren Yeah, but the extra-dose benefit is just company-reported, open-label data. Grain of salt.
Ash So it's the FDA decision that settles it, not this readout.
Wren Full tracker's at DreamLab Research.
0:30
TTS ModelsBreeze TTS 2 Leads Downloadable Models
0:42
HBOT & Red LightCustoms Can Hold Your Chamber
0:48
Hackable IP CamerasSupported List, Unsupported Camera
0:47
Software FactoriesTwo Agents Do Worse Than One
0:47
ESP32 & ESPHome EcosystemESPHome 2026.9.0 Released
0:45
Consumer Wearables You Can Still Own The Data FromGarmin's API Door Is Closed